Wave Life Sciences Is A Buy On Pipeline Prospects

Wave Life Sciences Ltd. (NASDAQ: WVE ) develops stereopure oligonucleotides using its PRISM platform to target disease-causing genetic mutations. A stereopure molecule is made with precise control over the stereochemistry at each chiral center, making the molecule more efficacious, but also saferAbout the TPT serviceThanks for reading. At the Total Pharma Tracker, we offer the following:-Our Android app and website features a set of tools for DIY investors, including a work-in-progress software where you ca ...